glp-1 receptor agonist list Indications for GLP-1/GIP RA Summary Sheet and Beyond! Table 1 from Cardiovascular Effects

Moreover, existing research has shown relative deficiencies in the collection of data concerning side effects and potential clinical risks

RELATED: Popular weight-loss and diabetes medications linked to lower risk of some cancers, study finds "One of the challenges that we have as clinicians is we know that some of these benefits help patients

GLP-1 receptor agonists are FDA-approved for type 2 diabetes and obesity, not autoimmune conditions

10.1056/NEJMoa2413258 89 SawadaN.AdachiK.NakamuraN.MiyabeM.ItoM.KobayashiS.et al (2020)

Exenatide in clinical trials The efficacy of twice-daily exenatide treatment of patients with T2D has been evaluated in multiple phase 3 clinical studies

In the UK, the drug was approved in 2007